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THE PROBLEM
Each day around the world, 830 women die from pregnancy- and childbirthrelated causes. In sub-Saharan Africa, 200,000 women die annually, and
in Southern Asia 66,000 die each year. The second most common cause
(after postpartum hemorrhage) is pre-eclampsia and eclampsia (PE/E)—lifethreatening, high blood pressure and excess protein in the urine after 20
weeks gestation. These deaths are preventable, yet essential medicines and
tools to treat this disorder are often unavailable in low-resource settings.

•

Pre-eclampsia is a condition
in pregnant women marked by an
increase in blood pressure and
protein in urine after 20 weeks
gestation.

•

Providing high quality antenatal
care improves the prevention and
early detection of pre-eclampsia
and can prevent its progression to
eclampsia.

•

The World Health Organization (WHO) recommends magnesium sulphate
(MgSO4) as the most effective, safe, and low-cost anticonvulsant treatment
for severe pre-eclampsia and eclampsia. Twenty-eight countries include
MgSO4 on their Essential Medicines List and have protocols on its use, but in
practice, the drug is often unavailable at community facilities or is not used in
compliance with guidelines.

Eclampsia is a life-threatening
condition characterized by
convulsions in women with
pre-eclampsia.

•

Women in developing countries
are 300 times more likely to die
from eclampsia than women in
developed countries.

PHC PE/E CORE MODEL DEVELOPMENT

•

Prescribing low-dose aspirin and
calcium to at-risk women can
lower their risk of developing
pre-eclampsia and eclampsia.

•

Severe pre-eclampsia can be
managed by administering
anti-hypertensive drugs and
magnesium sulphate (MgSO4).

•

MgSO4 is the safest and most
effective treatment for severe
PE/E.

•

Pre-eclampsia and other
hypertensive disorders in
pregnancy increase the risk of preterm births, which can lead to low
birth weight, anemia, and stunting.

•

Improved prevention, increased
detection, and effective treatment
of PE/E can prevent unnecessary
maternal and newborn deaths.

PE/E most often occurs during the second half of pregnancy, but can happen
before, during, or after delivery. It can lead to seizures, kidney and liver damage,
and death, and increases the risk of preterm births, low birth-weight, anemia,
and stunting. Women who have PE/E have an increased risk of developing
cardiovascular disease and other non-communicable diseases in later life.

Between 2008 and 2014, the Population Council implemented a twophase intervention, supported by the John D. and Catherine T. MacArthur
Foundation, in Bangladesh, Mexico, and Nigeria. The first phase (2008-2011)
involved training, mentoring, and supervising providers at secondary facilities
on detection and management of PE/E patients. This included training on the
administration of a loading dose of MgSO4. The providers then trained and
mentored additional providers at their respective health facilities on the use
of MgSO4.
The second phase of the intervention (2012-2014) focused on primary health
care (PHC) facilities, specifically on training PHC providers to administer a
modified loading dose of MgSO4 (intra-muscular only) and refer women to
secondary health facilities for monitoring. PHC providers received continued
technical support from trainings and routine mentorship.
The Council conducted an implementation research study to evaluate this
task shifting process around the prevention, detection, and management of
PE/E at the PHC level, hereby defined as the PHC PE/E Core Model. The study
showed that not only were PHC providers effectively able to carry out this task,
but maternal mortality in the intervention group decreased.
These components: Training PHC providers on detection and
management of PE/E, administration of a loading dose of MgSO4,
referral of women to secondary facilities for monitoring, and
reinforcing proper detection and management of PE/E at secondary
facilities are included in the PHC PE/E Core Model (Figure 1).
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PE/E in Brief

The Ending Eclampsia project seeks to expand
access to proven,underutilized interventions and
commodities for the prevention, early detection,
and treatment of pre-eclampsia and eclampsia and
strengthen global partnerships.

SCALE UP OF PHC PE/E CORE MODEL
The primary goal of the Ending Eclampsia project is
to expand the use of MgSO4 and other underutilized
commodities and strategies to prevent and treat preeclampsia and eclampsia (PE/E). Collaborating with
national policymakers, ministries of health, community
leaders, and health providers to increase access to highimpact, low-cost interventions.
The Ending Eclampsia project has been implementing the
PHC PE/E Core Model in select regions in Bangladesh,
Nigeria, and Pakistan. Replicating the core activities
was crucial to demonstrate that the PHC PE/E Core
Model is acceptable and feasible in varied settings.
Prior to initiating implementation of the PHC PE/E Core
Model, any organization--whether a ministry of health,
an international non-governmental organization, or
a local organization--must consider the reality on the
ground within the particular context. Monitoring data
and preliminary analyses across these three countries
indicate that task shifting of oral antihypertensive drugs
to PHCs is feasible and effective.

For the PHC PE/E Core Model to be the most
effective (Figure 1), as with any complex health
intervention, there is a certain health system
context that must be in place. This includes:
• Supportive policy environment;
• Collaborative stakeholder engagement;
• Sustained funding for health;
• Operational infrastructure;
• Adequate and skilled human resources; and
• Functioning supply chain for essential drugs
and commodities.

IDENTIFYING “PLUS” MODULES
Starting in 2016, Ending Eclampsia initiated six
implementation research studies in three countries
to identify and assess additional components that, in
conjunction with the Core Model, can further improve
prevention, detection, and management of PE/E.

FIGURE 1: PHC PE/Eplus Model
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Introducing antihypertensives at PHC
In Nigeria and Bangladesh, Ending Eclampsia introduced
an antihypertensive drug (oral methyldopa) at PHC level
to improve management of hypertension in pregnancy
with the ultimate goal of preventing progression to PE/E.
An antihypertensive drug module should be
included, if possible, in efforts to improve
prevention, detection, and management of PE/E
(Figure 1). This module requires the availability
of oral antihypertensive drugs that are safe for
use in pregnancy (alpha methyldopa), training of
PHC providers on the diagnosis of hypertension in
pregnancy and administration of antihypertensive
drugs, as well as how to provide adequate
explanation of the condition, management
protocols, and danger signs in pregnancy to
women with high blood pressure.
Engaging community women’s groups (Nigeria)
Women’s group leaders were trained on health
information that focused on antenatal care (ANC) and
postnatal care (PNC) using a simplified pictorial job aid
and log book to record activities.
Trained women’s group leaders provide health education
and information to their peers during their regular
meetings. The expectation is that in doing so, more
women will be empowered to use health facilities for
themselves or to encourage their relatives for ANC/
PNC. In this way, ANC attendance, pre-eclampsia case
detection and management, and quality of care for other
services will improve.
Community groups with women, men, or a mix
of the genders, can be targeted as channels
for sharing important health information with
communities (Figure 1). Clear, pictorial job aids
can be used to support the group leaders in
delivering key health messages about danger
signs in pregnancy, specifically PE/E to the
members of their group. Increased awareness
of PE/E can potentially lead to a woman seeking
care sooner than she would otherwise if she were
to experience complications in pregnancy.
Task-shifting to community midwives (Pakistan)
Through implementation research conducted in Pakistan,
researchers are assessing community midwives’ (CMWs)
ability to screen and detect PE/E cases, to provide a
modified loading dose of MgSO4 to the appropriate
clients, and to refer them for further management.
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In addition, this study aims to enhance the collaboration
between CMWs and local health workers (LHWs) by
encouraging LHWs to refer pregnant women for group
ANC sessions provided by local CMWs, and to improve
ANC and PNC counselling skills of CMWs so as to enable
them to manage postpartum hypertension.
Explore postnatal outcomes
About 25% of women with hypertensive disorders
in pregnancy (HDPs), especially those with a severe
condition, experience a deterioration of end organ
functions during puerperium (period spanning 6 – 8
weeks after delivery).In Bangladesh and Nigeria, Ending
Eclampsia researched health outcomes of women and
newborns after pregnancies complicated by HDPs and
followed up with them at nine weeks, six months and
one year after delivery to evaluate the nature of care
they received, assess their health status, and identify any
patterns in development of morbidities.
Trained nurses and midwives at the maternity unit conduct follow ups, which include reviewing treatment records from delivery onward, performing routine medical
checkups, and surveying participants.
The importance of postnatal care is not often
emphasized enough in any context. Women
who experienced hypertension in pregnancy are
particularly susceptible to ongoing complications
or morbidities. Therefore, we recommend that
PNC becomes a focus for essential care of women
with a history of hypertension in pregnancy
(Figure 1.)

NEXT STEPS
Detailed results of the Ending Eclampsia project in each
country will be available in 2019. Cross-country learnings
will further refine the PHC PE/Eplus Model as a framework
for global policy, program, and research strategies to
address the problem of hypertension in pregnancy
in a context-sensitive way. A package of step-wise
recommendations around task-shifting will be compiled
and disseminated for integration within country-level
maternal health strategies. At regional and global levels,
Ending Eclampsia plans to share the PHC PE/Eplus model,
related findings, and tools for adoption and scale up in
varied settings.
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